Shodimu-Emmanuel Olufemi
Overview
Explore the profile of Shodimu-Emmanuel Olufemi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eltayeb H, Stewart L, Morgem M, Johnson T, Nguyen M, Earl K, et al.
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569330
Cells produce free radicals and antioxidants when exposed to toxic compounds during cellular metabolism. However, free radicals are deleterious to lipids, proteins, and nucleic acids. Antioxidants neutralize and eliminate free...
2.
Raheem O, Olufemi S, Bachinski L, Vihola A, Sirito M, Holmlund-Hampf J, et al.
Am J Pathol
. 2010 Oct;
177(6):3025-36.
PMID: 20971734
The mutation that underlies myotonic dystrophy type 2 (DM2) is a (CCTG)n expansion in intron 1 of zinc finger protein 9 (ZNF9). It has been suggested that ZNF9 is of...
3.
Vihola A, Bachinski L, Sirito M, Olufemi S, Hajibashi S, Baggerly K, et al.
Acta Neuropathol
. 2010 Jan;
119(4):465-79.
PMID: 20066428
Aberrant transcription and mRNA processing of multiple genes due to RNA-mediated toxic gain-of-function has been suggested to cause the complex phenotype in myotonic dystrophies type 1 and 2 (DM1 and...
4.
Moore-Olufemi S, Olufemi S, Lott S, Sato N, Kozar R, Moore F, et al.
Dig Dis Sci
. 2009 Sep;
55(7):1866-77.
PMID: 19779973
Objective: Intestinal ischemia/reperfusion (IR) injury involves activation of inflammatory mediators, mucosal necrosis, ileus, and alteration in a variety of gene products. Ischemic preconditioning (IPC) reduced all the effects of intestinal...
5.
Bachinski L, Olufemi S, Zhou X, Wu C, Yip L, Shete S, et al.
Cancer Res
. 2005 Feb;
65(2):427-31.
PMID: 15695383
Li-Fraumeni syndrome (LFS) is a clinically and genetically heterogeneous inherited cancer syndrome. Most cases ( approximately 70%) identified and characterized to date are associated with dominantly inherited germ line mutations...